Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with stage IV non-small cell lung cancer: a retrospective study-Reference-Cited by-同舟云学术

Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with stage IV non-small cell lung cancer: a retrospective study

Published:2022-06 Issue:6 Volume:11 Page:1027-1037
ISSN:2218-6751
Container-title:Translational Lung Cancer Research
language:
Short-container-title:Transl Lung Cancer Res

Author:

Tian Tian,Yu Min,Yu Yang,Wang Ke,Tian Panwen,Luo Ziyue,Ding Zhenyu,Wang Ye,Gong Youling,Zhu Jiang,Zou Bingwen,Sio Terence T.,Alves Adelaide,Liu Yongmei,Huang Meijuan,Lu You

Publisher

AME Publishing Company

Subject

Oncology

Link

https://tlcr.amegroups.com/article/download/65988/pdf

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study;Journal of Clinical Oncology;2024-08-20

2. Application of combined ablation and immunotherapy in NSCLC and liver cancer: Current status and future prospects;Heliyon;2024-08

3. Immune checkpoint inhibitor (ICI)-based treatment beyond progression with prior immunotherapy in patients with driver-gene negative advanced non-small cell lung cancer;BMC Cancer;2024-05-07

4. Safety and efficacy of immune checkpoint inhibitor rechallenge in advanced non-small cell lung cancer: a retrospective study;Scientific Reports;2024-01-28

5. Genome-wide Analysis Identified SEMA4D, Novel Candidate Gene for Temperature Sensitivity in Patients With Non-Small Cell Lung Cancer;Integrative Cancer Therapies;2024-01